Midazolam Activates the Intrinsic Pathway of Apoptosis Independent of Benzodiazepine and Death Receptor Signaling

Background and Objectives: Midazolam has neurotoxic properties when administered neuraxially in vivo. Furthermore, midazolam induces neurodegeneration in neonatal animal models in combination with other general anesthetics. Therefore, this study focuses on the mechanism of neurotoxicity by midazolam in neuronal and nonneuronal cells. The study aims to evaluate the apoptotic pathway and to investigate the protective effects of the benzodiazepine antagonist flumazenil and the caspase inhibitor N-(2-quinolyl)valyl-aspartyl-(2,6-difluorophenoxy)-methylketone. Methods: The apoptosis-inducing effect of preservative-free midazolam on human lymphoma and neuroblastoma cell lines was evaluated using flow cytometric analysis of early apoptotic stages (annexin V/7AAD) and caspase 3 activation. B-cell lymphoma (Bcl2) protein overexpressing and caspase 9-deficient lymphoma cells were used to determine the role of the mitochondrial (intrinsic) pathway. Caspase 8-deficient and Fas-associated protein with death domain (FADD)-deficient cells were used to evaluate the death receptor (extrinsic) pathway. The protective effects of flumazenil and the caspase inhibitor N-(2-quinolyl)valyl-aspartyl-(2,6-difluorophenoxy)-methylketone were investigated in neuroblastoma cells and primary rat neurons using metabolic activity assays (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) and immunofluorescence microscopy. Results: Midazolam induced apoptosis in all investigated cell types in a concentration-dependent manner, indicated by flow cytometry. Bcl2-overexpression and caspase 9 deficiency protected against toxicity, whereas caspase 8 or FADD deficiency had no effect. Pancaspase inhibition had a strong protective effect, whereas flumazenil did not inhibit midazolam-induced apoptosis. Conclusions: Midazolam induces apoptosis via activation of the mitochondrial pathway in a concentration-dependent manner. The mechanism of midazolam toxicity switches from caspase-dependent apoptosis to necrosis with increasing concentrations. The induction of apoptosis and necrosis by midazolam is presumably unrelated to GABAA receptor pathway signaling.

[1]  A. Aliaga,et al.  TLN-4601 peripheral benzodiazepine receptor (PBR/TSPO) binding properties do not mediate apoptosis but confer tumor-specific accumulation. , 2010, Biochemical pharmacology.

[2]  M. Hollmann,et al.  Ketamine induces apoptosis via the mitochondrial pathway in human lympocytes and neuronal cells , 2012 .

[3]  P. Poon,et al.  The effect of midazolam on mouse Leydig cell steroidogenesis and apoptosis. , 2010, Toxicology letters.

[4]  David M. Conrad,et al.  The Ca2+ channel blocker flunarizine induces caspase-10-dependent apoptosis in Jurkat T-leukemia cells , 2010, Apoptosis.

[5]  F. Essmann,et al.  Apoptosis induction by different local anaesthetics in a neuroblastoma cell line. , 2009, British journal of anaesthesia.

[6]  G. Pilkington,et al.  Approaches to mitochondrially mediated cancer therapy. , 2008, Seminars in cancer biology.

[7]  K. Ho,et al.  Use of Intrathecal Midazolam to Improve Perioperative Analgesia: A Meta-Analysis , 2008, Anaesthesia and intensive care.

[8]  K. Schulze-Osthoff,et al.  Lidocaine induces apoptosis via the mitochondrial pathway independently of death receptor signaling , 2012 .

[9]  P. Lavand'homme,et al.  Lessons From Spinal Midazolam: When Misuse of Messages From Preclinical Models Exposes Patients to Unnecessary Risks , 2006, Regional Anesthesia & Pain Medicine.

[10]  G. Kahilogullari,et al.  The Neurotoxic Effects of Intrathecal Midazolam and Neostigmine in Rabbits , 2006, Anaesthesia and intensive care.

[11]  V. Jevtovic-Todorovic,et al.  Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways , 2005, Neuroscience.

[12]  Rajvir Singh,et al.  Analgesic Efficacy of Two Doses of Intrathecal Midazolam With Bupivacaine in Patients Undergoing Cesarean Delivery , 2005, Regional Anesthesia & Pain Medicine.

[13]  T. Yurtseven,et al.  Neurotoxicity with single dose intrathecal midazolam administration , 2005, European journal of anaesthesiology.

[14]  J. Olney,et al.  Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain , 2005, British journal of pharmacology.

[15]  L. Nguyen,et al.  Peripheral benzodiazepine receptor (PBR) ligand cytotoxicity unrelated to PBR expression. , 2005, Biochemical pharmacology.

[16]  C. Martini,et al.  Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. , 2004, Biochemical pharmacology.

[17]  T. Yaksh,et al.  The Use of Intrathecal Midazolam in Humans: A Case Study of Process , 2004, Anesthesia and analgesia.

[18]  C. Goodchild,et al.  Intrathecal Midazolam II: Combination with Intrathecal Fentanyl for Labor Pain , 2004, Anesthesia and analgesia.

[19]  S. Hassenbusch,et al.  Safety of Continuous Intrathecal Midazolam Infusion in the Sheep Model , 2004, Anesthesia and Analgesia.

[20]  J. Olney,et al.  Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits , 2003, The Journal of Neuroscience.

[21]  K. Drasner.  Local Anesthetic Neurotoxicity: Clinical Injury and Strategies That May Minimize Risk , 2002, Regional Anesthesia & Pain Medicine.

[22]  A. Rudra,et al.  Intrathecal midazolam for postoperative pain relief in caesarean section delivery. , 2001, Journal of the Indian Medical Association.

[23]  S. Erdine,et al.  Neurotoxicity of midazolam in the rabbit , 1999, Pain.

[24]  K. Furuya,et al.  Non‐GABAergic effects of midazolam, diazepam and flumazenil on voltage‐dependent ion currents in NG108‐15 cells , 1997, Neuroreport.

[25]  C. Goodchild,et al.  Antinociception by intrathecal midazolam involves endogenous neurotransmitters acting at spinal cord delta opioid receptors. , 1996, British journal of anaesthesia.

[26]  R. Prost,et al.  Magnetic Resonance Imaging of Cerebrospinal Fluid Volume and the Influence of Body Habitus and Abdominal Pressure , 1996, Anesthesiology.

[27]  J. Westman,et al.  Chronic Subarachnoid Midazolam (Dormicum) in the Rat: Morphologic Evidence of Spinal Cord Neurotoxicity , 1995, Regional Anesthesia & Pain Medicine.

[28]  J. Taxi,et al.  Subarachnoid Midazolam: Histologic Study in Rats and Report of Its Effect on Chronic Pain in Humans , 1991, Regional Anesthesia & Pain Medicine.

[29]  M. Pinaud,et al.  Ketamine and midazolam neurotoxicity in the rabbit. , 1991, Anesthesiology.

[30]  C. Goodchild,et al.  Intrathecal midazolam in the rat: evidence for spinally-mediated analgesia. , 1987, British journal of anaesthesia.

[31]  M. H. Kim,et al.  Intrathecal midazolam increases the analgesic effects of spinal blockade with bupivacaine in patients undergoing haemorrhoidectomy. , 2001, British journal of anaesthesia.

[32]  M. Yamakage,et al.  Inhibitory effects of diazepam and midazolam on Ca2+ and K+ channels in canine tracheal smooth muscle cells. , 1999, Anesthesiology.